Pfizer Says Its Vaccine Is Highly Effective in 5- to 11-Year-Olds

The company reported that a lower dose of the vaccine was 90.7 percent effective in preventing symptomatic Covid-19 in a clinical trial.

source https://www.nytimes.com/2021/10/22/us/politics/pfizer-vaccine-children-covid.html